Inactive Instrument

News Cytosorbents Corp OTC Bulletin Board

Equities

CTSO

US23283X1072

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

CytoSorbents Announces Regulatory Approval of CytoSorb® in Taiwan	04:31pm	GL
CytoSorbents Corporation Announces Regulatory Approval of CytoSorb® in Taiwan	04:30pm	CI
CytoSorbents Announces the Launch and Immediate Availability of the PuriFi™ Blood Pump in the European Union	13/06	GL
Cytosorbents Corporation Announces the Launch and Immediate Availability of the PuriFi Blood Pump in the European Union	13/06	CI
CytoSorbents to Host its 2024 Virtual Annual Stockholders Meeting	05/06	GL
CytoSorbents STAR Registry Data on Patients on Ticagrelor Undergoing CABG Surgery with CytoSorb Presented at EuroPCR 2024. Named Top Five Finalist for Best Scientific Abstract	04/06	GL
Earnings Flash (CTSO) CYTOSORBENTS Posts Q1 Revenue $9.8M, vs. Street Est of $9.79M	10/05	MT
Transcript : Cytosorbents Corporation, Q1 2024 Earnings Call, May 09, 2024	10/05
CytoSorbents: Q1 Earnings Snapshot	10/05	AQ
CytoSorbents Reports First Quarter 2024 Results	10/05	GL
Cytosorbents Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	10/05	CI
Transcript : Cytosorbents Corporation - Analyst/Investor Day	06/05
CytoSorbents May 6, 2024 Virtual KOL and Analyst-Investor Day: STAR-T Pivotal Trial Topline Results & Real World Experience with Antithrombotic Drug Removal in Europe	02/05	GL
CytoSorbents to Report First Quarter 2024 Operating and Financial Results	26/04	GL
STAR-T Pivotal Trial Results to Be Featured as a Late-Breaking Presentation at the 2024 American Association for Thoracic Surgery Annual Meeting	17/04	GL
Cytosorbents Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	15/03	CI
Earnings Flash (CTSO) CYTOSORBENTS Reports Q4 Revenue $8.7M, vs. Street Est of $9.8M	15/03	MT
CytoSorbents Reports Fourth Quarter and Full Year 2023 Results	15/03	GL
Transcript : Cytosorbents Corporation, Q4 2023 Earnings Call, Mar 14, 2024	15/03
CytoSorbents to Report Fiscal 2023 Operating and Financial Results	06/03	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Cytosorbents Corp OTC Bulletin Board

Equities

CTSO

US23283X1072

Summary

Filters